Your browser doesn't support javascript.
loading
Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19.
Sager, Jennifer E; El-Zailik, Asma; Passarell, Julie; Roepcke, Stefan; Li, Xiaobin; Aldinger, Melissa; Nader, Ahmed; Skingsley, Andrew; Alexander, Elizabeth L; Yeh, Wendy W; Mogalian, Erik; Garner, Chad; Peppercorn, Amanda; Shapiro, Adrienne E; Reyes, Maribel.
Afiliação
  • Sager JE; Vir Biotechnology, Inc., San Francisco, California, USA.
  • El-Zailik A; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Passarell J; Cognigen Division, Simulations Plus, Inc., Buffalo, New York, USA.
  • Roepcke S; Cognigen Division, Simulations Plus, Inc., Buffalo, New York, USA.
  • Li X; GSK, Upper Providence, Pennsylvania, USA.
  • Aldinger M; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Nader A; GSK, Upper Providence, Pennsylvania, USA.
  • Skingsley A; GSK, Brentford, UK.
  • Alexander EL; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Yeh WW; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Mogalian E; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Garner C; Vir Biotechnology, Inc., San Francisco, California, USA.
  • Peppercorn A; GSK, Cambridge, Massachusetts, USA.
  • Shapiro AE; Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Reyes M; Vir Biotechnology, Inc., San Francisco, California, USA.
CPT Pharmacometrics Syst Pharmacol ; 12(6): 853-864, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36922886
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article